A Multicenter, Randomized, Placebo Controlled, Double-blind, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Invossa K Injection in Patients Diagnosed as Knee Osteoarthritis With Kellgren & Lawrence Grade 2
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Jan 2018
At a glance
- Drugs Tonogenchoncel-L (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Kolon Life Science
- 19 Dec 2017 Status changed from planning to not yet recruiting.
- 29 Nov 2017 New trial record
- 23 Nov 2017 According to a Kolon Life Science media release, the Korean Ministry of Food and Drug Safety has granted approval to begin phase 3 clinical trials.